Literature DB >> 6603824

HLA studies in IgM rheumatoid-factor-positive arthritis of childhood.

L E Clemens, E Albert, B M Ansell.   

Abstract

The clinical course of children with IgM rheumatoid-factor-positive chronic arthritis closely resembles that of seropositive rheumatoid disease in adults. The frequency of HLA DR4 is known to be increased in adults with seropositive rheumatoid arthritis, but the first major report on childhood arthritis did not suggest a correlation, though only 8 seropositive cases were included. Fifty-two children with polyarthritis beginning before the age of 16 who persistently carried IgM rheumatoid factor were studied. HLA DR4 was present in 60% of these children but was found in only 29% of 93 patients with seronegative juvenile arthritis and 27% of a normal adult population. These results suggest immunogenetic similarities in patients with seropositive arthritis irrespective of age of onset.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603824      PMCID: PMC1001257          DOI: 10.1136/ard.42.4.431

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  HLA frequencies in less common arthropathies.

Authors:  A Robitaille; C Cockburn; D C James; B M Ansell
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

2.  Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27.

Authors:  J Edmonds; R I Morris; A L Metzger; R Bluestone; P I Terasaki; B Ansell; E G Bywaters
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

3.  The relationship of rheumatoid factor to age of onset in juvenile rheumatoid arthritis.

Authors:  V Hanson; E Drexler; H Kornreich
Journal:  Arthritis Rheum       Date:  1969-04

4.  Different HLA-D associations in adult and juvenile rheumatoid arthritis.

Authors:  P Stastny; C W Fink
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

5.  Histocompatibility antigens in childhood-onset arthritis.

Authors:  J G Schaller; H D Ochs; E D Thomas; B Nisperos; P Feigl; R J Wedgwood
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

6.  Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody.

Authors:  D Glass; D Litvin; K Wallace; L Chylack; M Garovoy; C B Carpenter; P H Schur
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

7.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

8.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

9.  B lymphocyte alloantigens in the study of the genetic basis of rheumatoid arthritis.

Authors:  G S Panayi; P H Wooley
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

10.  HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P H Wooley; J Griffin; G S Panayi; J R Batchelor; K I Welsh; T J Gibson
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

View more
  10 in total

1.  Hierarchy of risk of childhood-onset rheumatoid arthritis conferred by HLA-DRB1 alleles encoding the shared epitope.

Authors:  Sampath Prahalad; Susan D Thompson; Karen N Conneely; Yunxuan Jiang; Traci Leong; Jennifer Prozonic; Milton R Brown; Lori A Ponder; Sheila T Angeles-Han; Larry B Vogler; Christine Kennedy; Carol A Wallace; Carol A Wise; Marilynn Punaro; Ann Reed; Jane L Park; Elizabeth D Mellins; Andrew S Zeft; John F Bohnsack; David N Glass
Journal:  Arthritis Rheum       Date:  2012-03

2.  A model for the role of HLA-DQ molecules in the pathogenesis of juvenile chronic arthritis.

Authors:  J P Haas; A Andreas; B Rutkowski; H Brunner; E Keller; J Hoza; S Havelka; G Sierp; E D Albert
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 3.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 4.  Juvenile chronic arthritis--clinical sub-groups with particular relationship to adult patterns of disease.

Authors:  R C Allen; B M Ansell
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

5.  Rheumatoid arthritis, juvenile arthritis, iridocyclitis and the Epstein-Barr virus.

Authors:  A J Gear; P J Venables; J M Edwards; R N Maini; B M Ansell
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

6.  Class I associations and frequencies of class II HLA-DRB alleles by RFLP analysis in children with rheumatoid-factor-negative juvenile chronic arthritis.

Authors:  H I Brunner; E Ivaskova; J P Haas; A Andreas; E Keller; J Hoza; S Havelka; S Scholz; G Sierp; E D Albert
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

7.  Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing.

Authors:  H Okubo; K Itou; S Tanaka; N Watanabe; N Kashiwagi; F Obata
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

Review 8.  Autoantibody profile in juvenile chronic arthritis.

Authors:  A M Leak
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

Review 9.  Immunogenetics of juvenile idiopathic arthritis: A comprehensive review.

Authors:  Aimee O Hersh; Sampath Prahalad
Journal:  J Autoimmun       Date:  2015-08-21       Impact factor: 7.094

10.  PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.

Authors:  Kaori Hisa; Masakatsu D Yanagimachi; Takuya Naruto; Takako Miyamae; Masako Kikuchi; Rhoki Hara; Tomoyuki Imagawa; Shumpei Yokota; Masaaki Mori
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.